Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis

被引:2
|
作者
Holm-Yildiz, Sonja [1 ,10 ]
Dysgaard, Tina [1 ]
Krag, Thomas [1 ]
Pedersen, Britt Staevnsbo [1 ]
Hamm, Sebastian Rask [2 ]
Perez-Alos, Laura [3 ]
Hansen, Cecilie Bo [3 ]
Pries-Heje, Mia Marie [4 ]
Heftdal, Line Dam [2 ]
Hasselbalch, Rasmus Bo [5 ]
Fogh, Kamille [5 ]
Madsen, Johannes Roth [3 ]
Frikke-Schmidt, Ruth [6 ,7 ]
Hilsted, Linda Maria [6 ]
Sorensen, Erik [8 ]
Ostrowski, Sisse Rye [7 ,8 ]
Bundgaard, Henning [4 ,7 ]
Garred, Peter [3 ,7 ]
Iversen, Kasper [5 ,7 ,9 ]
Nielsen, Susanne Dam [2 ]
Vissing, John [1 ]
机构
[1] Univ Copenhagen, Copenhagen Neuromuscular Ctr, Righosp, Dept Neurol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Viro Immunol Res Unit, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Dept Clin Immunol, Righosp, Lab Mol Med, Sect 7631, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
[6] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark
[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[8] Copenhagen Univ Hosp, Dept Clin Immunol, Rigshosp, Copenhagen, Denmark
[9] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Emergency Med, Copenhagen, Denmark
[10] Rigshosp, Dept Neurol 8077, Inge Lehmanns Vej 8, DK-2100 Copenhagen, Denmark
关键词
Myasthenia gravis; COVID-19; vaccine; BNT162b2; Humoral response; TETANUS;
D O I
10.1016/j.jneuroim.2023.578215
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the humoral response to the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine in patients with myasthenia gravis on or off immunosuppressants and compared this to the response in healthy individuals. The SARS-CoV-2 IgG response and neutralizing capacity were measured in 83 patients (57 on immunosuppressants) and 332 healthy controls at baseline, three weeks, and two and six months after the vaccine. We found that the proportion of positive humoral response was lower in patients on immunosuppressants vs. controls at three weeks and two months (p <= 0.001), but not at six months post-vaccination (p = 0.379).
引用
收藏
页数:5
相关论文
共 50 条
  • [31] CLINICAL COURSE OF COVID-19 IN PATIENTS WITH PREEXISTING MYASTHENIA GRAVIS
    Daif, Ahmad
    Gapchup, Tejal
    Paul, Pritikanta
    MUSCLE & NERVE, 2022, 66 : S97 - S97
  • [32] Immune Response to COVID-19 Vaccine in Patients on Asthma Biologics
    Khurana, S.
    Kosoy, G.
    Norton, K.
    Cai, X.
    Gao, S.
    Miller, B.
    Georas, S. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
    Stascheit, Frauke
    Grittner, Ulrike
    Hoffmann, Sarah
    Mergenthaler, Philipp
    Schroeter, Michael
    Ruck, Tobias
    Pawlitzki, Mark
    Blaes, Franz
    Kaiser, Julia
    Schara, Ulrike
    Della-Marina, Adela
    Thieme, Andrea
    Hagenacker, Tim
    Jacobi, Christian
    Berger, Benjamin
    Urban, Peter P.
    Knop, Karl Christian
    Schalke, Berthold
    Lee, De-Hyung
    Kalischewski, Petra
    Wiendl, Heinz
    Meisel, Andreas
    JOURNAL OF NEUROLOGY, 2023, 270 (01) : 1 - 12
  • [34] TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE
    Zupanic, Sven
    Lazibat, Ines
    Majdak, Maja Rubinic
    Jelicic, Mia
    ACTA CLINICA CROATICA, 2021, 60 (03) : 496 - 509
  • [35] COVID-19 in patients with myasthenia gravis: Epidemiology and disease course
    Businaro, Pietro
    Vaghi, Gloria
    Marchioni, Enrico
    Diamanti, Luca
    Arceri, Sebastiano
    Bini, Paola
    Colombo, Elena
    Cosentino, Giuseppe
    Alfonsi, Enrico
    Costa, Alfredo
    Ravaglia, Sabrina
    Mallucci, Giulia
    Ballante, Elena
    Franciotta, Diego
    Gastaldi, Matteo
    MUSCLE & NERVE, 2021, 64 (02) : 206 - 211
  • [36] Impact of the COVID-19 pandemic on Myasthenia Gravis patients: A survey of the Myasthenia Gravis Foundation of America Registry
    De Leon-Benedetti, Andres
    Aban, Inmaculada
    McPherson, Tarrant
    Granit, Volkan
    Benatar, Michael
    Cutter, Gary
    Lee, Ikjae
    NEUROLOGY, 2021, 96 (15)
  • [37] A Study of Humoral Immune Response to Inactivated COVID-19 Vaccine in Patients with Psoriasis Receiving Biologics and Small Molecules
    Zou, Yang
    Peng, Yuting
    Xu, Jing
    Chen, Aijun
    Huang, Kun
    Wang, Ping
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17
  • [38] Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
    Seree-aphinan, Chutima
    Chanprapaph, Kumutnart
    Rattanakaemakorn, Ploysyne
    Setthaudom, Chavachol
    Suangtamai, Thanitta
    Pomsoong, Cherrin
    Ratanapokasatit, Yanisa
    Suchonwanit, Poonkiat
    FRONTIERS IN MEDICINE, 2021, 8
  • [39] Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study
    Ruan, Zhe
    Huan, Xiao
    Su, Yue
    Tang, Yong-Lan
    Meng, Dong-Dong
    Ren, Da-Lin
    Li, Chun-Hong
    Hao, Si-Jia
    Zhao, Chong-Bo
    Luo, Su-Shan
    Li, Zhu-Yi
    Chang, Ting
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Myasthenia Gravis Associated With COVID-19 Infection
    Sadiq, Waleed
    Waleed, Madeeha Subhan
    Rizvi, Taqi A.
    Khan, Shahkar
    El Hage, Halim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)